MicroRNA Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on MicroRNA Market 

5.1. COVID-19 Landscape: MicroRNA Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global MicroRNA Market, By Products

8.1. MicroRNA Market Revenue and Volume Forecast, by Products, 2024-2033

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Consumables

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global MicroRNA Market, By Services

9.1. MicroRNA Market Revenue and Volume Forecast, by Services, 2024-2033

9.1.1. Service Type

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Specimen

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global MicroRNA Market, By Application 

10.1. MicroRNA Market Revenue and Volume Forecast, by Application, 2024-2033

10.1.1. Cancer

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Infectious Diseases

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Immunological Disorder

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Cardiovascular Disease

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Neurological Disease

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

10.1.6. Others

10.1.6.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global MicroRNA Market, By End Use 

11.1. MicroRNA Market Revenue and Volume Forecast, by End Use, 2024-2033

11.1.1. Biotechnology & Pharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Academic & Government Research Institutes

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Other end-users

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global MicroRNA Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Services (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by End Use (2021-2033)

Chapter 13. Company Profiles

13.1. Merck KGaA

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. QIAGEN

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Synlogic

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GeneCopoeia, Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Horizon Discovery Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. New England Biolabs

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Quantabio

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. NanoString

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. BioGenex

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms